Bovie Medical Co. (NYSEAMERICAN:BVX) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday, November 6th.
Separately, Zacks Investment Research downgraded shares of Bovie Medical from a “hold” rating to a “sell” rating in a research note on Thursday, August 17th.
Bovie Medical (NYSEAMERICAN:BVX) traded up $0.02 on Monday, hitting $2.60. 62,579 shares of the stock were exchanged, compared to its average volume of 162,288. Bovie Medical has a one year low of $1.87 and a one year high of $4.35.
ILLEGAL ACTIVITY WARNING: “Bovie Medical Co. (NYSEMKT:BVX) Stock Rating Lowered by ValuEngine” was posted by BBNS and is the property of of BBNS. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://baseballnewssource.com/markets/bovie-medical-co-bvx-downgraded-by-valuengine-to-sell/1761785.html.
About Bovie Medical
Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Bovie Medical Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bovie Medical Co. and related companies with our FREE daily email newsletter.